Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 1,326 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Validation Clear all

Conditions: Physical Activity
Interventions: Not listed
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Neuropathic Pain From Spinal Cord Injury, Diabetic Peripheral Neuropathy, Post Herpetic Pain
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Visual Impairment
Interventions: Non invasive visual acuity testing; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Diabetic Retinopathy, Diabetic Eye Problems, Diabetic Macular Edema
Interventions: Color Fundus Photography, Mydriatics Agent, Optical Coherence Tomography (OCT); Procedure · Drug
Lead sponsor: RETINA-AI Health, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 3
States / cities: Houston, Texas

Conditions: Communication, Patient Care, Quality of Health Care
Interventions: mock handoff exposure, Introduction of CEX tool in Actual Hand-offs; Other
Lead sponsor: University of Chicago; Other
Eligibility: Not listed
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression Disorders, Anxiety Disorders
Interventions: Not listed
Lead sponsor: Deliberate Solutions Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy Control
Interventions: Trans-resveratrol, Concord grape juice, Grape seed polyphenol extract, Placebo; Dietary Supplement · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 55 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Lung Cancer
Interventions: comparative genomic hybridization, fluorescence in situ hybridization, gene expression analysis, microarray analysis, protein expression analysis, immunohistochemistry staining method, laboratory biomarker analysis, matrix-assisted laser desorption/ionization time of flight mass spectrometry, medical chart review, diagnostic bronchoscopy; Genetic · Other · Procedure
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 120 Years
Enrollment: 689 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2016
U.S. locations: 4
States / cities: Nashville, Tennessee

Conditions: Dental Pain
Interventions: Placebo, Ibuprofen; Drug
Lead sponsor: Lotus Clinical Research, LLC; Other
Eligibility: 18 Years to 40 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Sleep-Disordered Breathing, Sleep Architecture, Arrhythmia
Interventions: Belun Ring, Belun Cor; Device
Lead sponsor: Belun Technology Company Limited; Other
Eligibility: 18 Years to 80 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Chardon, Ohio • Cleveland, Ohio

Conditions: Spinal Metastases
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 219 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Disease
Interventions: Not listed
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Chromophobe Renal Cell Carcinoma, Clear Cell Papillary Renal Tumor, Clear Cell Renal Cell Carcinoma, Kidney Oncocytoma, Papillary Renal Cell Carcinoma, Urothelial Carcinoma
Interventions: Non-Interventional Study; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 589 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Laparoscopic Gynecological Surgery
Interventions: Eximis CS (Contained Segmentation) System; Device
Lead sponsor: Eximis Surgical; Industry
Eligibility: 21 Years to 49 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 7
States / cities: Greenwood Village, Colorado • Celebration, Florida • Sarasota, Florida + 4 more

Conditions: Hemophilia A
Interventions: Colorado Adult Joint Assessment Evaluation; Other
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 4
States / cities: Orange, California • Aurora, Colorado • Indianapolis, Indiana + 1 more

Conditions: Cardiac Disease
Interventions: PET-MRI; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cardiac Failure
Interventions: Cova Patch; Device
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Timeline: 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ostomy
Interventions: Ostom-i Alert Sensor; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pain
Interventions: anakinra, Placebo, Nociceptive pain challenge; Drug · Other
Lead sponsor: Alan Prossin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypoxia
Interventions: Pulse Oximeter, Blood Pressure, Respiratory Rate, Respiratory Gasses, Temperature; Device
Lead sponsor: Clinimark, LLC; Other
Eligibility: 18 Years to 50 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Blood Pressure
Interventions: Blood Pressure Measurement; Device
Lead sponsor: Fresenius Medical Care North America; Industry
Eligibility: 13 Years and older
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Continuous Renal Replacement Therapy, Renal Failure, Hemofilter Clotting
Interventions: Calculated Post-Filter Hematocrit, Measured Post-Filter Hematocrit; Other
Lead sponsor: Gwyndolyn M. Radford; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 13 Years to 24 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 14
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 10 more

Conditions: Major Depressive Disorder
Interventions: Dupilumab Injection; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 65 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Validation of Objective Measures of Place-Based Physical Activity

Validation Study of Neuropathic Pain

Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic

Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

Development and Validation of a Tool to Measure Hand-off Quality

Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety

Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery

Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor

Validation of Novel Predictive Score for Patients With Spinal Metastases

Validation of Peripheral Pressure Volume Loops and Ultrasound-derived "Cardiac Power" by Comparison With Invasive Left Ventricular Pressure Volume Loops

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

Human Factors Actual-Use Clinical Protocol

Colorado Adult Joint Assessment Scale (CAJAS) Validation

Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications

Validation of a Sensor for Non-invasive Measurement of Stroke Volume and Cardiac Output

Ostom-i Alert Sensor Quality of Life Validation

Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience

Hypoxia Blood Validation in Multiple Pulse Oximeters

Fresenius Noninvasive Blood Pressure Validation

Post-Filter Hematocrit

HIV Treatment-Readiness Measure (HTRM) Validation

Dupilumab in Major Depressive Disorder